Xenon Pharmaceuticals
XENE55
$42.55arrow_drop_up1.40%$0.59
XENE55
$42.55
arrow_drop_up1.40%Performance History
| Key Stats | |
|---|---|
| Open | $45.25 |
| Prev. Close | $45.00 |
| EPS | -2.73 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 43.78 | 45.51 |
| 52 Week Range | 27.98 | 50.99 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -2.73 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Xenon Pharmaceuticals (XENE)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Ian C. Mortimer C.M.A., CPA, CMA, CPA, M.B.A., MBA
- Headquarters
- Burnaby
- Employees
- 203
- Exchange
- NASDAQ
Keep an eye on Xenon Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Xenon Pharmaceuticals 's (XENE) price per share?
The current price per share for Xenon Pharmaceuticals (XENE) is $42.56. The stock has seen a price change of $0.59 recently, indicating a 1.41% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Xenon Pharmaceuticals (XENE)?
For Xenon Pharmaceuticals (XENE), the 52-week high is $50.99, which is 19.82% from the current price. The 52-week low is $27.98, the current price is 52.07% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Xenon Pharmaceuticals (XENE) a growth stock?
Xenon Pharmaceuticals (XENE) has shown an average price growth of -3.55% over the past three years. It has received a score of 67 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Xenon Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Xenon Pharmaceuticals (XENE) stock price performance year to date (YTD)?
As of the latest data, Xenon Pharmaceuticals (XENE) has a year-to-date price change of -5.24%. Over the past month, the stock has experienced a price change of 1.91%. Over the last three months, the change has been 9.68%. Over the past six months, the figure is 5.13%. Looking at a longer horizon, the five-year price change stands at 368.16%.
help
Is Xenon Pharmaceuticals (XENE) a profitable company?
Xenon Pharmaceuticals (XENE) has a net income of -$182.39M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$214.05M. Furthermore, the EBITDA is -$233.68M.
help
What is the market capitalization of Xenon Pharmaceuticals (XENE)?
Xenon Pharmaceuticals (XENE) has a market capitalization of $3.18B. The average daily trading volume is 42.04, indicating the stock's liquidity and investor engagement.
News
Jul 2, 2024
Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
CALENDAR OF EVENTS
CLINICAL STUDY
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
May 10, 2024
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
EARNINGS RELEASES AND OPERATING RESULTS
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
CALENDAR OF EVENTS
CONFERENCE CALLS/ WEBCASTS
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
CONFERENCE CALLS/ WEBCASTS
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference